Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „marketing“
Suchtreffer
Begriffe & Kennungen
Akynzeo · 4.8 · Post-marketing data indicates that the adverse reactions profile is generally similar to that seen in clinical
Eintrag öffnenAkynzeo · 4.8 · Post-marketing data indicates that the adverse reactions profile is generally similar to that seen in clinical
Eintrag öffnenAkynzeo · 4.8 · Post-marketing data indicates that the adverse reactions profile is generally similar to that seen in clinical
Eintrag öffnenAkynzeo · 4.8 · Post-marketing data indicates that the adverse reactions profile is generally similar to that seen in clinical
Eintrag öffnenAlhemo · 4.8 · The following adverse reactions are based on data from post-marketing surveillance and pooled data from the cl
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · Based on reports from literature and post-marketing experience orlistat may potentially reduce the absorption
Eintrag öffnenAlli (previously Orlistat GSK) · 4.8 · The frequencies of adverse reactions identified during post-marketing use of orlistat are not known as these r
Eintrag öffnenAlymsys · 4.8 · Post-marketing adverse reactions are included in both Tables 1 and 2, where applicable. Detailed information a
Eintrag öffnenAlymsys · 4.8 · Post-marketing experience
Eintrag öffnenAlymsys · 4.8 · Table 3. Adverse reactions reported in post-marketing setting
Eintrag öffnenAlymsys · 4.8 · a For further information please refer to Table 3 “Adverse reactions reported in post-marketing setting”. b Te
Eintrag öffnenAmbirix · 4.8 · The following adverse reactions were reported during post-marketing surveillance following vaccination with Am
Eintrag öffnenAmbirix · 4.8 · • Post-marketing data
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Decreased haemoglobin In the post-marketing period, cases of anaemia requiring blood cell transfusion have bee
Eintrag öffnenAmgevita · 4.8 · In post-marketing experience from January 2003 to December 2010, predominantly in patients with rheumatoid art
Eintrag öffnenAmgevita · 4.8 · In post-marketing experience from January 2003 to December 2010, predominantly in patients with rheumatoid art
Eintrag öffnenAmgevita · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmgevita · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmgevita · 4.8 · The following list of adverse reactions is based on experience from clinical trials and on post- marketing exp
Eintrag öffnenAmgevita · 4.8 · The following list of adverse reactions is based on experience from clinical trials and on post- marketing exp
Eintrag öffnen